Menu

Blog

Archive for the ‘biotech/medical’ category: Page 473

Aug 3, 2023

DNA tilts and stretches underlie differences in mutation rates across genomes

Posted by in categories: biotech/medical, chemistry, evolution, genetics, health

Each cell in the body stores its genetic information in DNA in a stable and protected form that is readily accessible for the cell to carry on its activities. Nevertheless, mutations—changes in genetic information—occur throughout the human genome and can have a powerful influence on human health and evolution.

“Our team is interested in a classical question about mutation—why do in the genome vary so tremendously from one DNA location to another? We just do not have a clear understanding of why this occurs,” said Dr. Md. Abul Hassan Samee, assistant professor of integrative physiology at Baylor College of Medicine and corresponding author of the work.

Previous studies have shown that the DNA sequences flanking a mutated position—the sequence context—play a strong role in the mutation rate. “But this explanation still leaves unanswered questions,” Samee said. “For example, one type of mutation occurs frequently in a specific sequence context while a different type of mutation occurs infrequently in that same sequence context. So, we think that a different mechanism could explain how mutation rates vary in the genome. We know that each building block or base that makes up a DNA sequence has its own 3D chemical shape. We proposed, therefore, that there is a connection between DNA shape and rates, and this paper shows that our idea was correct.”

Aug 3, 2023

Multi-omic rejuvenation and life span extension on exposure to youthful circulation

Posted by in categories: biotech/medical, genetics, life extension

Heterochronic parabiosis ameliorates age-related diseases in mice, but how it affects epigenetic aging and long-term health was not known. Here, the authors show that in mice exposure to young circulation leads to reduced epigenetic aging, an effect that persists for several months after removing the youthful circulation.

Aug 3, 2023

Matters Arising: The Information Theory of Aging Has Not Been Tested

Posted by in categories: biotech/medical, genetics, life extension, neuroscience

Yang and co-workers state that “using inducible changes to the epigenome, we find that the act of faithful DNA repair advances aging at physiological, cognitive, and molecular levels, including erosion of the epigenetic landscape, cellular exdifferentiation, senescence, and advancement of the DNA methylation clock, which can be reversed by OSK-mediated rejuvenation. These data are consistent with the information theory of aging, which states that a loss of epigenetic information is a reversible cause of aging.” There is extensive evidence that the key reagent, restriction endonuclease I-PpoI, is cytotoxic. Moreover, the corresponding author published two papers—neither cited—showing that I-PpoI targeted to specific cell types causes a p53 response and cell elimination within a month. Despite globally inducing I-PpoI activation for seven times as long as required to induce a progeric effect, no analysis of mice during this critical window was presented. No significant conclusion of Yang was demonstrated.

Aug 3, 2023

AI used to read breast cancer screenings a safe success

Posted by in categories: biotech/medical, health, robotics/AI

A study has revealed that AI can be used to detect cancer from mammogram screenings and could improve efficiencies and reduce workloads for health workers.

Aug 3, 2023

Tackling an aggressive, treatment-resistant lymphoma

Posted by in category: biotech/medical

Anaplastic large cell lymphoma, a form of non-Hodgkin lymphoma, is the most common aggressive lymphoma in children. Chemotherapy and radiation fail to cure about 30% of cases. When tumors are driven by the oncogene ALK—which is the case for the majority of children—kinase inhibitor drugs like crizotinib are very effective in blocking tumor growth. They also lack the serious side effects of chemotherapy.

However, ALK inhibitors also very expensive—about $80,000 a year—and must be taken for a lifetime. As soon as they’re stopped, the lymphoma comes back. Roberto Chiarle, MD, a hematopathologist and researcher at Boston Children’s Hospital, wanted to know why.

“ALK inhibitors can control the lymphoma, but you cannot reach a cure,” he says. “Why do persist for so long?”

Aug 3, 2023

A Protein Essential to the Fight Against Bacterial Invaders is Revealed

Posted by in category: biotech/medical

Scientists have shown that a protein called NLRP11 has an essential role in the immune system; it alerts the body that a bacterial infection is occurring, triggering an immune response that battles the bacterial invader. NLRP11 appears to identify bacteria that are taken up by immune cells called macrophages, by recognizing a part of the bacterial coat. These findings have provided new insights into our understanding of the immune response to bacterial infection, and have been reported in Science Immunology.

The NLRP11 protein is expressed by humans, but not mice, which are a common animal model for infection. In this study, the researchers overcame that gap by using a mouse model that expressed a so-called humanized immune system. Humanized mice have been grafted with human cells and tissues so they replicate human biological functions more accurately.

Aug 3, 2023

Central Florida is a hot spot for leprosy, report says

Posted by in categories: biotech/medical, health

Now, his team is cautioning other health care providers to be on the lookout for similar cases in the area.

According a research letter published by Nathoo and his colleagues in the journal Emerging Infectious Diseases, Central Florida has reported among the highest rates of leprosy in the United States.

In 2,020,159 cases were reported nationwide, compared with 200,000 new cases each year around the world, according to the World Health Organization. The new letter says Central Florida accounted for 81% of cases in Florida and nearly 1 out of 5 leprosy cases nationwide.

Aug 3, 2023

Mind Over Paralysis: AI Helps Quadriplegic Man Move and Feel Again

Posted by in categories: biotech/medical, health, robotics/AI

In an astounding medical first, researchers have used AI-powered brain implants to restore movement and sensation for a man who was paralyzed from the chest down.

Keith Thomas, 45, became a quadriplegic after a tragic diving accident damaged his C4 and C5 vertebrae in 2020. But thanks to pioneering work by scientists at Northwell Health’s Feinstein Institutes, Thomas can now move his arm simply by thinking about it. Even more remarkably, he can feel the touch of a hand for the first time in three years.


Advanced technology made the impossible possible after a double neural bypass changed the life of a paralyzed patient.

Aug 3, 2023

Screen for 500 Cancers & Diseases

Posted by in category: biotech/medical

At Prenuvo, we provide whole body, radiation-free MRI scans in order for our patients to focus on early detection of over 500 cancers and diseases.

Aug 3, 2023

World’s First Tooth Regrowth Medicine Enters Clinical Trials — ‘Every Dentist’s Dream’ Could Be A Life-Changing Reality

Posted by in categories: biotech/medical, genetics

A pioneering dental medicine project in Japan is making strides toward clinical trials, with the aim of becoming the world’s first tooth-regrowing treatment, according to the country’s national news site Mainichi.

The upcoming trial will be focused on patients affected by anodontia, a genetic condition characterized by the absence of teeth, or partial anodontia, where people are missing some teeth, as described by the National Organization for Rare Disorders (NORD).

Clinical trials are scheduled to begin next July in Japan. If successful, regulatory approval for the tooth-regrowing medicine is anticipated by 2030, potentially heralding groundbreaking advancements in dentistry.

Page 473 of 2,683First470471472473474475476477Last